31
Participants
Start Date
October 31, 2007
Primary Completion Date
June 30, 2009
Study Completion Date
October 31, 2009
bortezomib
1.3 mg/m\^2 on days 1, 4, 8, 11
bendamustine
90 mg/m\^2 days 1 and 4
rituximab
375 mg/m\^2 day 1
Cornell Wiell Medical College, New York
University of Rochester Medical Center (James P. Wilmot Cancer Center), Rochester
Nebraska Medical Center, Omaha
Collaborators (2)
Millennium Pharmaceuticals, Inc.
INDUSTRY
Cephalon
INDUSTRY
University of Rochester
OTHER